Lam KS - Search Results

1

C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance.

Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS. Tan KC, et al. Among authors: lam ks, lam th. Diabetes Care. 2003 Aug;26(8):2323-8. doi: 10.2337/diacare.26.8.2323. Diabetes Care. 2003. PMID: 12882856

2

Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.

Tan KC, Chow WS, Tam SC, Ai VH, Lam CH, Lam KS. Tan KC, et al. Among authors: lam ks, lam ch. J Clin Endocrinol Metab. 2002 Feb;87(2):563-8. doi: 10.1210/jcem.87.2.8249. J Clin Endocrinol Metab. 2002. PMID: 11836286 Clinical Trial.

3

Diabetic nephropathy is associated with the 5'-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes.

Liu YF, Wat NM, Chung SS, Ko BC, Lam KS. Liu YF, et al. Among authors: lam ks. Diabet Med. 2002 Feb;19(2):113-8. doi: 10.1046/j.1464-5491.2002.00632.x. Diabet Med. 2002. PMID: 11874426

4

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.

Tan KC, Chow WS, Ai VH, Lam KS. Tan KC, et al. Among authors: lam ks. Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):71-6. doi: 10.1002/dmrr.255. Diabetes Metab Res Rev. 2002. PMID: 11921421 Free article. Clinical Trial.

5

Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus.

Tan KC, O K, Chow WS, Ai VH, Siow YL, Lam KS. Tan KC, et al. Among authors: lam ks. Eur J Clin Invest. 2002 May;32(5):328-34. doi: 10.1046/j.1365-2362.2002.00990.x. Eur J Clin Invest. 2002. PMID: 12027872

6

Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS. Tan KC, et al. Among authors: lam ks. Diabetes Care. 2002 Jun;25(6):1055-9. doi: 10.2337/diacare.25.6.1055. Diabetes Care. 2002. PMID: 12032114

7

Mutations in the hepatocyte nuclear factor-1alpha gene in Chinese MODY families: prevalence and functional analysis.

Xu JY, Chan V, Zhang WY, Wat NM, Lam KS. Xu JY, et al. Among authors: lam ks. Diabetologia. 2002 May;45(5):744-6. doi: 10.1007/s00125-002-0814-9. Epub 2002 Apr 3. Diabetologia. 2002. PMID: 12107757

8

Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.

Tan KC, Tso AW, Tam SC, Pang RW, Lam KS. Tan KC, et al. Among authors: lam ks. Diabet Med. 2002 Nov;19(11):944-8. doi: 10.1046/j.1464-5491.2002.00823.x. Diabet Med. 2002. PMID: 12421432 Clinical Trial.

9

Multiple endocrine neoplasia type 2A in Chinese families.

Lo CY, Wat NM, Lam KY, Tiu SC, Chan J, Lam KS. Lo CY, et al. Among authors: lam ky, lam ks. Clin Endocrinol (Oxf). 2003 Apr;58(4):528. doi: 10.1046/j.1365-2265.2003.01732.x. Clin Endocrinol (Oxf). 2003. PMID: 12641638 No abstract available.

10

Effects of a promoter variation in the hepatic glucokinase gene on promoter activity and glucose tolerance in Southern Chinese subjects.

Zhang M, Tan KC, Zhang WY, Xu JY, Wat NM, Chung SS, Janus ED, Lam KS. Zhang M, et al. Among authors: lam ks. Clin Genet. 2003 Mar;63(3):232-4. doi: 10.1034/j.1399-0004.2003.00041.x. Clin Genet. 2003. PMID: 12694236 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

983 results

Search Page

Filters